[ad_1]
Breast cancer screening is not recommended for low risk of bad cancer
Researchers have now found that if women are at low risk for bad cancer, doctors and physicians should avoid screening. Such bad cancer screening harms women more than it does and leads to unnecessary tests and treatments.
Researchers at University College London found that women at low risk of bad cancer did not have a bad cancer screening program. should be submitted. Because it often leads to overdiagnosis and stress in the affected women. The doctors published the results of their study in the English language journal "JAMA Oncology".
Which women should be screened for bad cancer?
Only 72 percent of women who have been invited to have a bad exam actually go to such a test. The researchers say that each woman's genetic testing and education about her individual risk could lead to screening only 70% of the most-at-risk women, while the 30% risk would not require a mammogram all the three years.
About 300 genetic variants a risk factor
Selective testing would do more good than harm, experts say. This would not only reduce overdiagnosis and stress for women, but would also be more cost-effective. It is known that there are about 300 genetic variants badociated with bad cancer. The combination of lifestyle factors and bad cancer in the family of women plays an important role, says the author of the study. Nora Pashayan from University College London. The risk is increased, for example, by smoking, obesity, the absence of the child and abstinence, the doctor continues.
Discover the general risk of bad cancer through genetic testing
Every woman should have a genetic test If she belongs to 30 percent of women with a low risk of bad cancer, who do not have really need screening, the scientists report. The technology is already available in the UK, but the test is not yet supported by the NHS, according to experts. The research team has been working on screening risk badessment for several years. In Europe and the United States, studies are being conducted on women undergoing bad examinations. Routine genetic testing should be supported by the NHS this fall. From the first of October, British hospitals will be connected to specialized centers capable of interpreting DNA tests for patients, say the authors. This will allow drug treatments to be better suited for cancer. The process could also be beneficial in bad cancer screening.
Should high-risk women be examined more often?
If women are at a low risk of bad cancer, that does not mean that they can not contract bad cancer. Have bad cancer. The team also explored the question of whether high-risk women should be screened more frequently. Some women develop fast-growing cancer in the interval between triennial mammograms, the doctors explain.
Women were divided into different groups
The scientists divided the subjects into three groups. One group included women who had not been screened for bad cancer. A second group of women regularly perform mammograms every three years, aged 50 to 69 years. A third group included women at low risk of bad cancer who were not screened, but also high-risk women. The model of bad examination should be modified, so that the conclusion of the researchers in light of the results of the study. Women are individuals with different risks and lifestyles. They should receive a screening tailored to their own profile, says study author, Professor Fiona Gilbert. (As)
Source link